16 magg 2018 anni - FDA approved Lucemyra (lofexidine hydrochloride), the first non-opioid treatment for the mitigation of withdrawal symptoms associated with abrupt discontinuation of opioids.
Aggiunto al nastro di tempo:
Data:
16 magg 2018 anni
Adesso
~ 7 years and 5 months ago